With darting red and green beams above me and large mechanical eyes and grids humming and moving around me, I feel as though I’m in a 1950s sci-fi movie.

AstraZeneca AZN announced that the European Commission has approved its blockbuster cancer drug, Imfinzi (durvalumab), for a ...

Lung cancer among never-smokers is rising worldwide. In one U.S. study of 12,000 lung cancer patients, the share of people who didn’t smoke rose from 8 to 15 percent over twenty years.

Earlier diagnoses and advancements in treatment options are providing hope for patients with endometrial cancer like Yaca.

Northwestern’s iSeg tool matches expert doctors and finds hidden cancer zones, with clinical rollout expected soon.

Studies presented at the ASCO Annual Meeting 2025 highlighted immunotherapies that may provide new standards of care for certain cancers as well as immunotherapies that are breaking new ground by ...

Targeted Oncology connects oncology professionals with updates on immunotherapy, biomarkers, cancer pathways, and targeted ...

Screening for disease, including cancer, can cause harm —during screening, diagnosis and treatment. With lung cancer ...

RadNet incorporates artificial intelligence (AI) into low-dose computed tomography (LDCT) screening for lung cancer – advancing lung cancer detection at its earliest stages. LDCT screening for lung ...

The medicines have dangerous potency levels, either too low to fight cancer effectively or so high such that they poison ...

The new lung cancer screening program needs to be independently evaluated to keep it on track, and to minimise the harms.

Research from the NIH’s National Cancer Institute, an agency beleaguered by funding cuts and censorship, finds that ...